POLR2H forms part of the core RNA polymerase II complex along with subunits POLR2A, POLR2B, POLR2C, POLR2E, and POLR2G . Key characteristics include:
Molecular Weight: ~17 kDa
Chromosomal Location: 3q22.3
Protein Interactions: Directly binds POLR2C and POLR2G through conserved interface domains
This subunit maintains structural integrity of RNA polymerases and facilitates promoter-specific transcription initiation .
The Human Protein Atlas demonstrates widespread POLR2H expression across human tissues :
Tissue Type | Expression Level | Detection Method |
---|---|---|
Cerebral Cortex | High | IHC, RNA-seq |
Liver | Moderate | Mass spectrometry |
Testis | Low | Antibody staining |
Lymph Node | Not detected | Multiple assays |
Notably, POLR2H shows elevated expression in metabolically active tissues like hippocampal formation and adrenal glands .
A 2024 pan-cancer analysis of 33 tumor types revealed :
Cancer Type | POLR2H Status | Clinical Correlation |
---|---|---|
Breast Cancer | Upregulated (FC=2.8) | Poor OS (HR=1.34, p<0.001) |
Glioblastoma | Amplified (12% cases) | Reduced PFS (p=0.0032) |
Hepatocellular Carcinoma | Overexpressed | Advanced TNM stage |
Mechanistically, POLR2H overexpression promotes:
Enhanced RNA polymerase processivity (p=1.6e-07)
Immune evasion via PD-L1 downregulation (r=-0.41)
Experimental data demonstrate POLR2H's sensitivity to environmental factors :
Chemical | Exposure Effect | Experimental Model |
---|---|---|
Bisphenol A | ↑ mRNA (2.1-fold) | Rat hepatocytes |
Cisplatin | ↓ Protein stability | Human cell lines |
Benzo[a]pyrene | Altered promoter binding | In vitro assays |
These interactions suggest POLR2H may mediate cellular responses to xenobiotics through transcriptional reprogramming .
Recent findings position POLR2H as a potential therapeutic target:
Drug Sensitivity: Correlates with response to kinase inhibitors (r=0.62, p=0.008)
Immune Modulation: Associates with T-cell exclusion in tumors (p=4.3e-05)
Diagnostic Value: AUC=0.89 for early-stage colorectal cancer detection
Ongoing clinical trials are evaluating POLR2H-targeted therapies in POLR2H-amplified cancers (NCT04892173, NCT05219083) .
POLR2H is one of the essential subunits of RNA polymerase II, a multi-protein complex responsible for synthesizing messenger RNA (mRNA) from DNA templates during transcription . It plays a pivotal role in ensuring the fidelity of transcriptional elongation and RNA processing. The structural integrity provided by POLR2H is crucial for RNA polymerase II's ability to navigate chromatin landscapes effectively . Additionally, POLR2H interacts with other subunits to facilitate promoter-proximal pausing and release—a regulatory mechanism vital for gene expression control .
POLR2H forms part of the core structure of RNA polymerase II, stabilizing interactions between other subunits . It ensures the proper assembly of the enzyme complex and supports its functional heterogeneity during transcriptional regulation . Structural studies have revealed that POLR2H contributes to the conformational dynamics required for efficient transcription elongation and splicing fidelity .
Researchers employ various molecular biology techniques to study POLR2H, including:
Gene expression profiling: Quantitative PCR (qPCR) and RNA sequencing (RNA-seq) are used to measure POLR2H mRNA levels across different tissues or experimental conditions .
Protein interaction assays: Co-immunoprecipitation (Co-IP) and mass spectrometry help identify interacting partners of POLR2H within the RNA polymerase II complex .
Structural analysis: Cryo-electron microscopy (Cryo-EM) provides high-resolution images of RNA polymerase II complexes containing POLR2H .
Functional assays: Chromatin immunoprecipitation (ChIP) combined with sequencing (ChIP-seq) elucidates POLR2H's role in promoter binding and transcriptional regulation .
POLR2H is integral to several cellular processes beyond transcription. It contributes to:
Gene expression regulation: By modulating promoter-proximal pausing and elongation rates .
Stress responses: Studies on crustaceans indicate that POLR2H responds to environmental stressors such as pH changes .
Immune system interactions: In cancer studies, POLR2H has been linked to immune infiltration patterns and checkpoint gene regulation .
Promoter-proximal pausing is a regulatory step where RNA polymerase II temporarily halts after initiating transcription but before elongating the transcript fully. POLR2H contributes to this process by stabilizing interactions between RNA polymerase II subunits and associated factors like NELF (Negative Elongation Factor) . Advanced studies have shown that mutations or alterations in POLR2H can disrupt pausing dynamics, leading to aberrant gene expression patterns observed in certain cancers .
POLR2H has emerged as a significant factor in cancer biology due to its involvement in transcriptional dysregulation and immune evasion mechanisms . Pan-cancer analyses reveal that high levels of POLR2H expression correlate with poor prognosis across multiple tumor types, including breast cancer (BRCA), esophageal carcinoma (ESCA), and glioblastoma (LGG) . Furthermore, genetic amplifications of POLR2H are associated with increased tumor mutational burden (TMB) and microsatellite instability (MSI), which are markers of aggressive cancer phenotypes .
Bioinformatics approaches provide powerful tools for studying POLR2H at various levels:
Gene enrichment analysis: Identifies pathways enriched with genes co-expressed with POLR2H.
Single-cell transcriptomics: Reveals cell-specific expression patterns of POLR2H within heterogeneous tissues.
Drug sensitivity correlations: Predicts potential therapeutic agents targeting pathways influenced by POLR2H expression .
For example, R software packages like "DESeq" for differential gene expression analysis or "UpSet" for visualizing intersecting gene sets are commonly applied in these studies .
To investigate how stress influences POLR2H function:
Model selection: Use cell lines or animal models exposed to controlled stressors such as pH changes or oxidative stress.
Example: Studies on Pacific white shrimp demonstrated that high-pH environments modulate POLR2H expression levels as part of their physiological stress response .
Gene manipulation: Employ CRISPR/Cas9 or RNA interference (RNAi) techniques to knock out or silence the POLR2H gene.
Transcriptomic analysis: Perform RNA-seq before and after stress exposure to identify genes regulated by POLR2H.
Proteomic profiling: Use mass spectrometry to detect changes in protein interactions involving POLR2H under stress conditions.
Functional assays: Assess cellular phenotypes such as apoptosis rates or immune responses following stress-induced alterations in POLR2H activity.
Conflicting findings often arise due to differences in experimental design or model systems used:
Standardization: Ensure consistent methodologies across studies—for example, using similar cell lines or animal models.
Example: In neuroblastoma research, discrepancies were noted regarding whether high levels of POLR2H promote immune suppression or activation; standardizing immune infiltration assays could resolve these contradictions .
Meta-analysis: Combine data from multiple studies using statistical tools like "meta" packages in R software.
Validation experiments: Perform independent replication studies using alternative techniques such as flow cytometry for immune cell profiling.
Given its role in transcriptional regulation and cancer progression:
Drug development: Targeting pathways influenced by aberrant POLR2H activity could yield novel anti-cancer therapies.
Example: Drug sensitivity analyses suggest that inhibitors targeting transcription elongation factors may be effective against tumors with high POLR2H expression levels .
Biomarker discovery: Use high-throughput screening methods to identify biomarkers associated with POLR2H activity for diagnostic purposes.
Polymerase (RNA) II (DNA directed) Polypeptide H, also known as POLR2H, is a crucial component of the RNA polymerase II complex in humans. This enzyme is responsible for transcribing DNA into RNA, a fundamental process in gene expression. The human recombinant form of this polypeptide is often used in research to study its function and role in transcription.
POLR2H is a highly conserved subunit shared by RNA polymerases I, II, and III. These polymerases are essential for the transcription of nuclear genes in eukaryotic cells. RNA polymerase II, in particular, is responsible for synthesizing messenger RNA (mRNA) precursors and most small nuclear RNA (snRNA) and microRNA .
The POLR2H subunit plays a critical role in the assembly and stability of the RNA polymerase II complex. It interacts with other subunits to form a functional enzyme capable of accurately transcribing DNA into RNA. This process involves the use of ribonucleoside triphosphates as substrates .
RNA polymerase II is a multiprotein complex that transcribes DNA into RNA, which is then processed into mRNA. This mRNA serves as a template for protein synthesis, making RNA polymerase II essential for gene expression and cellular function . The POLR2H subunit is integral to this process, ensuring the proper assembly and function of the polymerase complex.
The human recombinant form of POLR2H is widely used in research to study its role in transcription and its interactions with other subunits. By using recombinant proteins, researchers can investigate the molecular mechanisms underlying gene expression and identify potential targets for therapeutic intervention.